3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Plasma cell
1
Conditions
Sarcoma
1
Osteosarcoma
1
Neoplasms, Plasma Cell
1
Multiple Myeloma
1
Mobility Limitation
1
COVID-19
1
Breast Neoplasms
1
Interventions
Dexamethasone
40
Lenalidomide
26
Bortezomib
21
daratumumab
20
pomalidomide
19
Cyclophosphamide
14
Specimen Handling
13
Biopsy
13
carfilzomib
12
talquetamab
9
Magnetic Resonance Spectroscopy
9
Calcium Dobesilate
9
isatuximab
8
Melphalan
8
iberdomide
7
fludarabine
7
belantamab mafodotin
6
X-Rays
5
selinexor
4
fludarabine phosphate
4
elotuzumab
4
Nuclear Medicine Department, Hospital
4
trametinib
3
tocilizumab
3
dexamethasone acetate
3
dexamethasone 21-phosphate
3
dabrafenib
3
auricularum
3
Whole-Body Irradiation
3
Thalidomide
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Multiple Myeloma
×
Patient Reported Outcome Measures
×
30 days
×
Clear all
NCT05831787
2026-05-18
COSMIC
ASH Research Collaborative
Completed
201 enrolled
15 charts